HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects.

BMC Med Genet

Department of Critical Medicine, Second People's Hospital of Mudanjiang, Mudanjiang, 157000, Heilongjiang Province, China.

Published: May 2020

AI Article Synopsis

  • The study investigates the association between the HTRA1 gene polymorphism (rs11200638) and age-related macular degeneration (AMD), revealing that individuals with the A-allele or AA genotype may have a higher risk of developing AMD.
  • A meta-analysis of 35 studies indicated that this genetic factor is significantly linked to AMD in both Asian and Caucasian populations, with stronger associations found for wet AMD (OR: 3.40) compared to dry AMD (OR: 2.08).
  • The findings suggest that further research with larger sample sizes and a focus on gene-environment interactions is needed to better understand the role of this polymorphism in AMD development.

Article Abstract

Background: The high-temperature requirement factor A1 (HTRA1) gene located at 10q26 locus has been associated with age-related macular degenerative (AMD), with the significantly related polymorphism being (rs11200638, -625G/A), however, above association is not consistent. We investigated a comprehensive analysis to evaluate the correlations between rs11200638 polymorphism and AMD susceptibility thoroughly addressing this issue.

Methods: An identification was covered from the PubMed and Wanfang databases until 27th Jan, 2020. Odds ratios (OR) with 95% confidence intervals (CI) were applied to evaluate the associations. After a thorough and meticulous search, 35 different articles (33 case-control studies with HWE, 22 case-control studies about wet/dry AMD) were retrieved.

Results: Individuals carrying A-allele or AA genotype may have an increased risk to be AMD disease. For example, there has a significantly increased relationship between rs11200638 polymorphism and AMD both for Asians (OR: 2.51, 95%CI: 2.22-2.83 for allelic contrast) and Caucasians [OR (95%CI) = 2.63(2.29-3.02) for allelic contrast]. Moreover, a similar trend in the source of control was detected. To classify the type of AMD, increased association was also observed in both wet (OR: 3.40, 95%CI: 2.90-3.99 for dominant model) and dry (OR: 2.08, 95%CI: 1.24-3.48 for dominant model) AMD. Finally, based on the different genotyping methods, increased relationships were identified by sequencing, TaqMan, PCR-RFLP and RT-PCR.

Conclusions: Our meta-analysis demonstrated that HTRA1 rs11200638 polymorphism may be related to the AMD development, especially about individuals carrying A-allele or AA genotype, who may be as identified targets to detect and intervene in advance. Further studies using Larger sample size studies, including information about gene-environment interactions will be necessary to carry out.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229611PMC
http://dx.doi.org/10.1186/s12881-020-01047-5DOI Listing

Publication Analysis

Top Keywords

rs11200638 polymorphism
12
polymorphism amd
12
amd
9
htra1 rs11200638
8
comprehensive analysis
8
case-control studies
8
individuals carrying
8
carrying a-allele
8
a-allele genotype
8
dominant model
8

Similar Publications

Article Synopsis
  • * Researchers found that SNP rs11200647 had a significant association with myopia, particularly moderate myopia, and that other SNPs also showed nominal associations.
  • * The results imply that there may be shared genetic factors between myopia and age-related macular degeneration (AMD), providing new insights into the genetics of myopia.
View Article and Find Full Text PDF

Background: To identify genotypes associated with neovascular age-related macular degeneration (nAMD) and investigate the associations between genotype variations and anti-vascular endothelial growth factor (VEGF) treatment response.

Methods: This observational, retrospective, case series study enrolled patients diagnosed with nAMD who received anti-VEGF treatment in National Taiwan University Hospital with at least one-year follow-up between 2012 and 2020. A genome-wide association study (GWAS) was conducted on enrolled patients and controls.

View Article and Find Full Text PDF

Purpose: To determine whether genetic risk single nucleotide polymorphisms (SNPs) for age-related macular degeneration (AMD) influence short-term response to intravitreal ranibizumab treatment.

Methods: Forty-four treatment-naive AMD patients were included in a prospective observational study. They underwent three monthly injections of intravitreal ranibizumab for neovascular AMD.

View Article and Find Full Text PDF

CRISPR editing demonstrates rs10490924 raised oxidative stress in iPSC-derived retinal cells from patients with -related AMD.

Proc Natl Acad Sci U S A

May 2023

Jonas Children's Vision Care, Department of Ophthalmology, Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032.

Genome-wide association studies (GWAS) have identified genetic risk loci for age-related macular degeneration (AMD) on the chromosome 10q26 (Chr10) locus and are tightly linked: the A69S (G>T) rs10490924 single-nucleotide variant (SNV) and the AATAA-rich insertion-deletion (indel, del443/ins54), which are found in the age-related maculopathy susceptibility 2 () gene, and the G512A (G>A) rs11200638 SNV, which is found in the high-temperature requirement A serine peptidase 1 () promoter. The fourth variant is Y402H complement factor H (), which directs  signaling. CRISPR manipulation of retinal pigment epithelium (RPE) cells may allow one to isolate the effects of the individual SNV and thus identify SNV-specific effects on cell phenotype.

View Article and Find Full Text PDF

Age-related macular degeneration (AMD) is the main cause of severe vision loss in elderly populations of the developed world with limited therapeutic medications available. It is a multifactorial disease with a strong genetic susceptibility which exhibits the differential genetic landscapes among different ethnic groups. To investigate the Han Chinese-specific genetic variants for AMD development and progression, we have presented a genome-wide association study (GWAS) on 339 AMD cases and 3,390 controls of a Han Chinese population recruited from the Taiwan Precision Medicine Initiative (TPMI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!